Literature DB >> 14620520

Use of a physiologic bicarbonate buffer system for dissolution characterization of ionizable drugs.

Daniel P McNamara1, Katherine M Whitney, Sandra L Goss.   

Abstract

PURPOSE: The aim of this study was to examine if sparging with CO2(g) could be used to establish stable biorelevant bicarbonate buffers, in aqueous medium, for use in dissolution characterization of low-solubility ionizable drugs.
METHODS: Preparation of the bicarbonate-containing dissolution medium was monitored by use of a commercially available fiberoptic probe to measure the concentration of dissolved CO2(aq). Intrinsic dissolution measurements at 100 rpm, 37 degrees C for indomethacin and dipyridamole were performed using a rotating disk and UV detection at pH 6.8 and 5.0 in a USP dissolution vessel apparatus.
RESULTS: Indomethacin dissolution at pH 6.8 was significantly impacted by the concentration of CO2(g) in the sparging gas. Dipyridamole flux at pH 6.8 was independent of buffer species or buffer concentrations studied. However, dipyridamole dissolution at pH 5 was also a strong function of the concentration of CO2(g) in the sparging gas.
CONCLUSIONS: Stable bicarbonate biorelevant buffers could be established to perform intrinsic dissolution rate determinations for indomethacin and dipyridamole as long a continuous gas sparging of CO2(g) was used. Depending of the pH of the dissolution medium, the intrinsic dissolution rates of both indomethacin and dipyridamole were affected by the bicarbonate concentration. Sparging with CO2(g) to create physiologic buffers has a unique advantage over conventional buffers in that gas sparging serves as a continuous source of bicarbonate buffer species. This advantage was demonstrated by performing dissolution experiments at pH values typically associated with the fed state (pH 5) and applying relatively low CO2(g) pressures, resulting in bicarbonate concentrations less than 0.5 mM. It was demonstrated that CO2(g) sparging at a pH consistent with the fed state created an in-situ bicarbonate buffer at low concentrations, which had a significant impact on the dissolution of a basic drug such as dipyridamole.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14620520     DOI: 10.1023/a:1026147620304

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  15 in total

1.  Forecasting the oral absorption behavior of poorly soluble weak bases using solubility and dissolution studies in biorelevant media.

Authors:  Edmund S Kostewicz; Ulrich Brauns; Robert Becker; Jennifer B Dressman
Journal:  Pharm Res       Date:  2002-03       Impact factor: 4.200

2.  Titration curves for gastric secretion. A study on duodenal ulcer and gastric ulcer with particular reference to the effect of glycopyrronium.

Authors:  M Kristensen
Journal:  Scand J Gastroenterol Suppl       Date:  1975

3.  Human duodenal mucosal brush border Na(+)/H(+) exchangers NHE2 and NHE3 alter net bicarbonate movement.

Authors:  M Repishti; D L Hogan; V Pratha; L Davydova; M Donowitz; C M Tse; J I Isenberg
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-07       Impact factor: 4.052

4.  Intestinal secretion: stimulation by peptides.

Authors:  G O Barbezat; M I Grossman
Journal:  Science       Date:  1971-10-22       Impact factor: 47.728

5.  Carbon dioxide tensions in the proximal part of the canine gastrointestinal tract.

Authors:  S J Rune; F W Henriksen
Journal:  Gastroenterology       Date:  1969-04       Impact factor: 22.682

6.  Dissolution of carboxylic acids. III: The effect of polyionizable buffers.

Authors:  J G Aunins; M Z Southard; R A Myers; K J Himmelstein; V J Stella
Journal:  J Pharm Sci       Date:  1985-12       Impact factor: 3.534

7.  The buffer capacity and buffer systems of human whole saliva measured without loss of CO2.

Authors:  A Bardow; D Moe; B Nyvad; B Nauntofte
Journal:  Arch Oral Biol       Date:  2000-01       Impact factor: 2.633

8.  A review of the physiology of the canine digestive tract related to the development of in vitro systems.

Authors:  M Smeets-Peeters; T Watson; M Minekus; R Havenaar
Journal:  Nutr Res Rev       Date:  1998-06       Impact factor: 7.800

9.  A demonstration of bicarbonate production by the normal human stomach in vivo.

Authors:  W D Rees; D Botham; L A Turnberg
Journal:  Dig Dis Sci       Date:  1982-11       Impact factor: 3.199

10.  Dissolution kinetics of carboxylic acids II: effect of buffers.

Authors:  K G Mooney; M A Mintun; K J Himmelstein; V J Stella
Journal:  J Pharm Sci       Date:  1981-01       Impact factor: 3.534

View more
  8 in total

1.  Characterization of the human upper gastrointestinal contents under conditions simulating bioavailability/bioequivalence studies.

Authors:  Lida Kalantzi; Konstantinos Goumas; Vasilios Kalioras; Bertil Abrahamsson; Jennifer B Dressman; Christos Reppas
Journal:  Pharm Res       Date:  2006-12-01       Impact factor: 4.200

2.  Multivariate data analysis of factors affecting the in vitro dissolution rate and the apparent solubility for a model basic drug substance in aqueous media.

Authors:  Anita Maria Persson; Curt Pettersson; Josefin Rosén
Journal:  Pharm Res       Date:  2010-03-27       Impact factor: 4.200

3.  Canine intestinal contents vs. simulated media for the assessment of solubility of two weak bases in the human small intestinal contents.

Authors:  Lida Kalantzi; Eva Persson; Britta Polentarutti; Bertil Abrahamsson; Konstantinos Goumas; Jennifer B Dressman; Christos Reppas
Journal:  Pharm Res       Date:  2006-05-25       Impact factor: 4.200

4.  Synergistic Inorganic Carbon and Denitrification Genes Contributed to Nitrite Accumulation in a Hydrogen-Based Membrane Biofilm Reactor.

Authors:  Si Pang; Bruce E Rittmann; Chengyang Wu; Lin Yang; Jingzhou Zhou; Siqing Xia
Journal:  Bioengineering (Basel)       Date:  2022-05-20

5.  Toward an in vivo dissolution methodology: a comparison of phosphate and bicarbonate buffers.

Authors:  Jennifer J Sheng; Daniel P McNamara; Gordon L Amidon
Journal:  Mol Pharm       Date:  2009 Jan-Feb       Impact factor: 4.939

6.  Measuring the Impact of Gastrointestinal Variables on the Systemic Outcome of Two Suspensions of Posaconazole by a PBPK Model.

Authors:  Bart Hens; Arjang Talattof; Paulo Paixão; Marival Bermejo; Yasuhiro Tsume; Raimar Löbenberg; Gordon L Amidon
Journal:  AAPS J       Date:  2018-03-29       Impact factor: 4.009

7.  An automated system for monitoring and regulating the pH of bicarbonate buffers.

Authors:  Grzegorz Garbacz; Bartosz Kołodziej; Mirko Koziolek; Werner Weitschies; Sandra Klein
Journal:  AAPS PharmSciTech       Date:  2013-03-07       Impact factor: 3.246

8.  Controlling Indomethacin Release through Vapor-Phase Deposited Hydrogel Films by Adjusting the Cross-linker Density.

Authors:  Paul Christian; Stephan Tumphart; Heike M A Ehmann; Hans Riegler; Anna Maria Coclite; Oliver Werzer
Journal:  Sci Rep       Date:  2018-05-08       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.